Navigation Links
APIC Launches First National C. Difficile Prevalence Study
Date:3/20/2008

Data to Reveal Nationwide Extent of Life-threatening Infection in Healthcare Facilities

WASHINGTON, March 20 /PRNewswire-USNewswire/ -- The Association for Professionals in Infection Control and Epidemiology (APIC) today announced a detailed strategy to combat Clostridium difficile-associated disease (CDAD). The initiative begins with the first national prevalence study to gain a better understanding of the spread of this virulent pathogen.

C. difficile is a life-threatening bacterium that causes diarrhea and more serious intestinal conditions such as colitis and is frequently associated with prolonged antibiotic use. CDAD is most commonly contracted by the elderly and those with recent exposure to hospitals, nursing homes and other healthcare institutions. Over the past several years, a more toxic strain of C. difficile has emerged causing outbreaks in healthcare facilities worldwide.

"We are concerned by reports of increasing infection rates and severity of CDAD," said APIC Chief Executive Officer Kathy L. Warye. "Not only does it lead to longer hospital stays, which result in higher healthcare costs, but deaths from C. difficile infections also are on the rise. Because the true magnitude of this infection is unknown, our objective is to provide the first national estimate of C. difficile infection in inpatients in U.S. healthcare facilities."

The APIC Research Foundation C. difficile Prevalence Study will be conducted May 1 to May 23, 2008. More than 5,000 healthcare facilities are being invited to participate by providing a one-day snapshot of C. difficile infections within their institution.

Following the survey, APIC will develop a Guide to the Elimination of C. difficile, including strategies for controlling transmission as well as an educational Webinar series. The Association also will hold a conference in late 2008, featuring results of the prevalence study, along with the latest science, epidemiology and best practices for the elimination of C. difficile transmission.

"Following our positive experience in having taken a very comprehensive approach to MRSA in 2007, APIC will launch a similar aggressive fight against C. difficile in 2008," said Warye. "APIC will lead a national effort to arm infection prevention professionals with the comprehensive tools necessary to eradicate this virulent pathogen and reduce C. difficile infections. Prevention efforts are crucial because our arsenal of effective treatment agents is thin, and the organism is rapidly developing resistance."

For more information, please visit the APIC Research Foundation at http://www.apic.org.

APIC's mission is to improve health and patient safety by reducing risks of infection and other adverse outcomes. The Association's nearly 12,000 members have primary responsibility for infection prevention, control and hospital epidemiology in healthcare settings around the globe. APIC advances its mission through education, research, collaboration, practice guidance, public policy, and credentialing.

APIC Research Foundation funds and conducts studies to answer key research questions that will advance the understanding and practice of infection and control. The Foundation brings together infection prevention and control professionals (ICPs), epidemiologists, researchers, industry and other members of the healthcare community to evaluate the efficacy of infection prevention practices and evaluate new approaches to reduce the risk of infection and save lives.


'/>"/>
SOURCE Association for Professionals in Infection Control andEpidemiology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NHS Choices Launches New Fitness Section
2. APIC launches first national C. difficile prevalence study
3. Sagent Pharmaceuticals Launches Ciprofloxacin Injection, USP, 5% Dextrose Premix Bag
4. NHS Choices Launches New Good Food Package
5. eMPR Digital Drug Reference Reaches 50,000 Downloads and the Publisher Launches a Raffle for Healthcare Providers
6. Ford Launches Warriors in Pink Mustang for 09, Doubles Contributions To Race For The Cure
7. NHS Choices Launches New Autism Package
8. Intercim Launches Pertinence Suite Powered by Velocity
9. NHS Choices Launches Guide to Child Health Aged 0-1
10. Globus Medical Launches NIKO(TM) Corpectomy Spacer System
11. PinnacleCare Launches Health Records Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 ... ... the patient payment industry today announced its strategic partnership with Connance, a ... workflows. , The two companies’ proven, proprietary technology combine to provide health ...
(Date:6/27/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
Breaking Medicine Technology: